全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Synthesis and Antioxidant Activity of 2-Amino-5-methylthiazol Derivatives Containing 1,3,4-Oxadiazole-2-thiol Moiety

DOI: 10.1155/2013/620718

Full-Text   Cite this paper   Add to My Lib

Abstract:

A series of new 5-(2-amino-5-methylthiazol-4-yl)-1,3,4-oxadiazole-2-thiol derivatives 6(a–j) were designed and synthesized with various substituted aldehydes. The chemical structures were confirmed by elemental analyses, FT-IR, 1H NMR, and mass spectral studies. The antioxidant activity of the synthesized compounds was evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH), hydroxyl, nitric oxide, and superoxide radical scavenging assay methods. Compounds 6a, 6e, and 6c showed significant radical scavenging potential due to the presence of electron donating substituent on substituted aldehydes. 1. Introduction Compounds containing azomethine group (–C=N–) in the structure are known as Schiff bases which are usually synthesized by the condensation of primary amines and active carbonyl groups. Schiff bases are found to exhibit multifunctional properties, and they are able to improve various biological and pharmacological activities such as antitumor, antioxidant, and antibacterial activities [1]. Schiff bases bearing heterocyclic residues possessing excellent biological activity have attracted the attention of many researchers in recent years [2]. Due to the great flexibility and diverse structural aspects of Schiff bases, a wide range of these compounds have been synthesized and their activities have been studied [3, 4]. Many Schiff bases are known to be medicinally important and are used to design medicinal compounds [5]. 1,3,4-Oxadiazoles and thiazoles are versatile leading molecules for designing potential bioactive agents. The derivatives of these molecules constitute an important family of heterocyclic compounds. Compounds bearing 1,3,4-oxadiazole nucleus are known to exhibit remarkable biological activities such as antimalarial, anticancer, anticonvulsant, and anti-inflammatory [6–12]. Thiazole nucleus is also an integral part of all the available penicillins which have revolutionized the therapy of bacterial diseases [13]. The applications of thiazoles were found in the drug development for the treatment of allergies, hypertension, inflammation, schizophrenia, bacterial, HIV infections, hypnotics, and so forth [14]. Free radicals such as superoxide, hydroxyl, and nitric oxide are the oxygen centered free radicals, and they are also called reactive oxygen species (ROS). They are generated in the human body and would cause damage to lipids, proteins, and DNA and thus may lead to various diseases such as carcinogenesis, drug-associated toxicity, and inflammation. Furthermore, radical reactions play a significant role in the development of life limiting

References

[1]  P. Mishra, H. Rajak, and A. Mehta, “Synthesis of Schiff bases of 2-amino-5-aryl-1,3,4-oxadiazoles and their evaluation for antimicrobial activities,” Journal of General and Applied Microbiology, vol. 51, no. 2, pp. 133–141, 2005.
[2]  B. Shivarama Holla, B. Sooryanarayana Rao, K. Shridhara, and P. M. Akberali, “Studies on arylfuran derivatives: part XI. Synthesis, characterisation and biological studies on some Mannich bases carrying 2,4-dichlorophenylfurfural moiety,” Farmaco, vol. 55, no. 5, pp. 338–344, 2000.
[3]  N. Raman, V. Muthuraj, S. Ravichandran, and A. Kulandaisamy, “Synthesis, characterisation and electrochemical behaviour of Cu(II), Co(II), Ni(II) and Zn(II) complexes derived from acetylacetone and p-anisidine and their antimicrobial activity,” Proceedings of the Indian Academy of Sciences, vol. 115, no. 3, pp. 161–167, 2003.
[4]  R. Capdeville, E. Buchdunger, J. Zimmermann, and A. Matter, “Glivec (ST1571, imatinib), a rationally developed, targeted anticancer drug,” Nature Reviews Drug Discovery, vol. 1, no. 7, pp. 493–502, 2002.
[5]  J. Moskovitz, M. B. Yim, and P. B. Chock, “Free radicals and disease,” Archives of Biochemistry and Biophysics, vol. 397, no. 2, pp. 354–359, 2002.
[6]  O. Prakash, M. Kumar, R. Kumar, C. Sharma, and K. R. Aneja, “Hypervalent iodine(III) mediated synthesis of novel unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles as antibacterial and antifungal agents,” European Journal of Medicinal Chemistry, vol. 45, no. 9, pp. 4252–4257, 2010.
[7]  ?. G. Kü?ükgüzel, E. E. Oru?, S. Rollas, F. ?ahin, and A. ?zbek, “Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds,” European Journal of Medicinal Chemistry, vol. 37, no. 3, pp. 197–206, 2002.
[8]  P. R. Kagthara, N. S. Shah, R. K. Doshi, and H. H. Parekh, “Synthesis of 2, 5-disubstituted 1, 3, 4-oxadiazoles as biologically active heterocycles,” Indian Journal of Chemistry B, vol. 38, no. 5, pp. 572–576, 1999.
[9]  M. Amir, S. A. Javed, and H. Kumar, “Synthesis of some 1,3,4-oxadiazole derivatives as potential anti-inflammatory agents,” Indian Journal of Chemistry B, vol. 46, no. 6, pp. 1014–1019, 2007.
[10]  A. Zarghi, S. A. Tabatabai, M. Faizi et al., “Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 7, pp. 1863–1865, 2005.
[11]  Y. Kotaiah, N. Harikrishna, K. Nagaraju, and C. Venkata Rao, “Synthesis and antioxidant activity of 1, 3, 4-oxadiazole tagged thieno[2, 3-d] pyrimidine derivatives,” European Journal of Medicinal Chemistry, vol. 58, pp. 340–345, 2012.
[12]  S. ?ncü, M. Punar, and H. Eraksoy, “Comparative activities of β-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates,” Chemotherapy, vol. 50, no. 2, pp. 98–100, 2004.
[13]  F. A. Hassan, “Synthesis, characterization, anti-inflammatory, and antioxidant activities of some new thiazole derivatives,” International Journal of Applied Science and Technology, vol. 2, no. 7, pp. 180–187, 2012.
[14]  N. Siddiqui, M. Faiz Arshad, W. Ahsan, and M. S. Alam, “Thiazoles: a Valuable insight into the recent advances and biological activities,” International Journal Pharmaceutical Sciences and Drug Research, vol. 1, no. 3, pp. 136–143, 2009.
[15]  O. I. Aruoma, “Free radicals, oxidative stress, and antioxidants in human health and disease,” Journal of the American Oil Chemists' Society, vol. 75, no. 2, pp. 199–212, 1998.
[16]  B. N. Ames, M. K. Shigenaga, and T. M. Hagen, “Oxidants, antioxidants, and the degenerative diseases of aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 7915–7922, 1993.
[17]  Y. K. Tyagi, A. Kumar, H. G. Raj et al., “Synthesis of novel amino and acetyl amino-4-methylcoumarins and evaluation of their antioxidant activity,” European Journal of Medicinal Chemistry, vol. 40, no. 4, pp. 413–420, 2005.
[18]  P. Karegoudar, M. S. Karthikeyan, D. J. Prasad, M. Mahalinga, B. S. Holla, and N. S. Kumari, “Synthesis of some novel 2,4-disubstituted thiazoles as possible antimicrobial agents,” European Journal of Medicinal Chemistry, vol. 43, no. 2, pp. 261–267, 2008.
[19]  S. Santosh Kumar, K. I. Priyadarsini, and K. B. Sainis, “Free radical scavenging activity of vanillin and o-vanillin using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical,” Redox Report, vol. 7, no. 1, pp. 35–40, 2002.
[20]  E. Rollet-Labelle, M.-J. Grange, C. Elbim, C. Marquetty, M.-A. Gougerot-Pocidalo, and C. Pasquier, “Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis,” Free Radical Biology and Medicine, vol. 24, no. 4, pp. 563–572, 1998.
[21]  S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991.
[22]  C.-Y. Hsu, “Antioxidant activity of extract from Polygonum aviculare L,” Biological Research, vol. 39, no. 2, pp. 281–288, 2006.
[23]  M. S. Blois, “Antioxidant determinations by the use of a stable free radical,” Nature, vol. 181, no. 4617, pp. 1199–1200, 1958.
[24]  B. Halliwell, J. M. C. Gutteridge, and O. I. Aruoma, “The deoxyribose method: a simple “test-tube” assay for determination of rate constants for reactions of hydroxyl radicals,” Analytical Biochemistry, vol. 165, no. 1, pp. 215–219, 1987.
[25]  D. C. Garrat, The Quantitative Analysis of Drugs, Chapman and Hall, Tokyo, Japan, 3rd edition, 1964.
[26]  D. Kovala-Demertzi, A. Galani, M. A. Demertzis, S. Skoulika, and C. Kotoglou, “Binuclear copper(II) complexes of tolfenamic: synthesis, crystal structure, spectroscopy and superoxide dismutase activity,” Journal of Inorganic Biochemistry, vol. 98, no. 2, pp. 358–364, 2004.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133